What timing of vaccination is potentially dangerous for children younger than 2 years?

Pauline Gras1, Anne-Charlotte Bailly1, Marion Lagrée1,2

  • 1a Univ. Lille, CHU Lille, Pediatric Emergency Unit & Infectious Diseases , Lille , France.

Insights

Identifying dangerous vaccination delays is crucial for child health. This study defined critical timelines for vaccine doses to prevent disease, aiming to improve pediatric immunization effectiveness.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunization Practices
  • Public Health

Background:

  • Vaccine-preventable diseases persist despite high coverage rates.
  • Late or untimely vaccinations may contribute to disease occurrence in children.
  • Defining safe vaccination windows is essential for effective public health strategies.

Purpose of the Study:

  • To identify potentially dangerous vaccination delays for each vaccine dose in children under two years old.
  • To establish consensus among experts on maximum acceptable delays for pediatric vaccinations.
  • To inform future studies on vaccine effectiveness and improve childhood immunization quality.

Main Methods:

  • A 3-round Delphi process involving 37 French pediatric vaccine experts.
  • Literature review to generate items for 10 vaccine doses recommended before age two.
  • A 70% consensus cutoff was used for item reduction and consensus building.

Main Results:

  • Consensus was reached on maximum acceptable delays for 6 out of 10 vaccine doses.
  • Specific delays were identified: 15 days for DTaP-IPV/Hib, 1 month for MenC, and by age 11 for HepB completion.
  • These defined delays serve as critical indicators for vaccine timeliness.

Conclusions:

  • The Delphi process successfully identified critical vaccination delays for children under two.
  • These findings provide new indicators for assessing vaccine effectiveness and timeliness.
  • Improving adherence to these vaccination schedules can enhance protection against preventable diseases in children.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
53.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
705
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
2
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
664
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K